Previous findings showed that breast cancer patients with higher levels of infiltrating immune cells had more favorable prognoses, specifically with a higher ratio of tumor-infiltrating cytotoxic CD8 T cells (TILs) to immunosuppressive FoxP3+ T regulatory cells (T reg) (5). This evidence concerns the gene FOXP3 and breast cancer.